Nasdaq, S&P rise 1% driving day two of stock gains
U.S. stocks rose for the second straight session as traders digested positive economic news and the Food and Drug Administration’s approval of Pfizer’s COVID-19 pill for use in adults and children ages 12 and older.
Ticker | Security | Last | Change | Change % |
---|---|---|---|---|
I:DJI | DOW JONES AVERAGES | 35753.89 | +261.19 | +0.74% |
SP500 | S&P 500 | 4696.56 | +47.33 | +1.02% |
I:COMP | NASDAQ COMPOSITE INDEX | 15521.89237 | +180.81 | +1.18% |
The Dow Jones Industrial Average rose 261 points or 0.6% building on its 560 point advance on Tuesday while the S&P 500 and Nasdaq Composite rose 1% each.
Positive economic data included an uptick in the Consumer Confidence Index to the best level since July, a better than expected 3Q GDP report of 2.3%, albeit well below July’s 6.7% jump and home sales that rose 1.9%.
And the fight